Homesearch
Services
Industries
About
Partnerships
Insights
Careers
careers logo
We are looking for the best
Are you one of the top 10% in your field? Do you have a passion for technology and want to make a difference? If so, we are looking for you!
DISCOVER OPENINGS
Investors
arrows logo
NASDAQ CM: GDYN
$12.15
Jun 6, 2025 4:00 PM EDT
Get in touch
search
Need low-risk e-commerce wins? Our B2B Playbook webinar series has your next move—RSVP now. Need low-risk e-commerce wins? Our B2B Playbook webinar series has your next move—RSVP now.
Home Insights All authors VP Singh
VP Singh

VP Singh

VP holds an MS in Pharma Marketing and Management with 17+ years of experience in the Healthcare and Pharma industry. As a strategic leader, he excels in crafting enterprise-wide commercial strategies, implementing integrated analytics strategies, establishing analytic centers of excellence, and utilizing real-world data sources. His expertise spans pharmaceutical landscapes, practice leadership and client consulting, commercial insights generation, and AI/ML adoption. With previous leadership roles at Bayer US Pharma and Bristol Myers Squibb, he now serves as an SME in Healthcare and Pharma Practice at Grid Dynamics, focusing on analytical frameworks and offerings to empower key stakeholders in the healthcare system. He is passionate about leveraging the power of data science, real-world data, and emerging technologies, including AI, ML, and Generative AI, to drive digital transformation.

Check out the latest insights

From lab to market cover
Article
How generative AI is reducing drug development timelines
Artificial intelligence
Digital engagement
+1
Article How generative AI is reducing drug development timelines

Did you know that the journey for a groundbreaking drug from concept to market spans a staggering 12 to 18 years, with a jaw-dropping price tag of $2.6 billion? What’s more, only a tiny 10% of candidates even make it to clinical trials. But here's the good news–Generative AI is stepping in to res...

Artificial intelligence
Digital engagement
+1
A book cover with the text Maximizing AI's full potential in pharma
White Paper
Maximizing AI’s full potential in pharma: Shifting from pilots to strategic integration
Artificial intelligence
Digital engagement
+1
White Paper Maximizing AI’s full potential in pharma: Shifting from pilots to strategic integration

In a world where artificial intelligence (AI) is transforming industries, the pharmaceutical sector faces unique challenges in fully embracing this technological revolution. Often, the industry experiences a multitude of isolated AI pilot projects that struggle to transition into full-scale product...

Artificial intelligence
Digital engagement
+1

Get in touch

Let's connect! How can we reach you?

    Invalid phone format
    Submitting

    Please sign up for email alerts if you would like to receive information related to press releases, investor relations, and regulatory filings.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    How generative AI is reducing drug development timelines

    Thank you!

    It is very important to be in touch with you.
    We will get back to you soon. Have a great day!

    check

    Something went wrong...

    There are possible difficulties with connection or other issues.
    Please try again after some time.

    Retry